Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Receptor Profile : Cagrilintide acts as a nonselective agonist at amylin receptors (AMY1/2/3) and the calcitonin receptor, which are involved in appetite regulation, gastric emptying, and energy homeostasis
Research demonstrates thymosin beta-4 was identified as a gene upregulated 4-6-fold during early blood vessel formation and promotes growth of new blood cells from existing vessels
ARA-290 Research Protocols and Handling The clinical trial protocol for ARA-290 is well-established: 4 mg administered subcutaneously once daily for 28 days
Check with your provider for details
The wolverine peptide is not a single compound
US$ 20.63
US$ 22.28
US$ 23.47
US$ 25.69
US$ 25.79
